Structures by: Goud N. R.
Total: 20
Phenobarbital
C12H12N2O3
Chemical communications (Cambridge, England) (2016) 52, 23 4389-4392
a=13.0764(3)Å b=6.72680(10)Å c=26.5912(18)Å
α=90.00° β=99.083(7)° γ=90.00°
Phenobarbital
C12H12N2O3
Chemical communications (Cambridge, England) (2016) 52, 23 4389-4392
a=14.5744(4)Å b=6.88000(19)Å c=22.9964(16)Å
α=90.00° β=93.987(7)° γ=90.00°
Sulfacetamide-acetamide
C8H10N2O3S.C2H5NO
CrystEngComm (2013) 15, 37 7456
a=11.2134(6)Å b=7.7976(4)Å c=16.1280(7)Å
α=90.00° β=103.260(5)° γ=90.00°
Sulfacetamide-acetamide
C8H10N2O3S.C2H5NO
CrystEngComm (2013) 15, 37 7456
a=22.2392(16)Å b=8.4705(4)Å c=14.7710(11)Å
α=90.00° β=107.056(8)° γ=90.00°
Aceclofenac-piperazine(0.5)-hydrate
C18H20Cl2N2O5
Crystal Growth & Design (2013) 13, 4 1590
a=14.555(4)Å b=14.950(4)Å c=8.557(3)Å
α=90.00° β=92.473(4)° γ=90.00°
8(C16H18FN3O3),8(H2O),O
8(C16H18FN3O3),8(H2O),O
Crystal Growth & Design (2008) 8, 12 4343
a=17.4911(16)Å b=8.9542(8)Å c=19.7990(18)Å
α=90.00° β=90.255(2)° γ=90.00°
C16H18FN3O3.13,H2O
C16H18FN3O3.13,H2O
Crystal Growth & Design (2008) 8, 12 4343
a=8.7445(8)Å b=8.9531(8)Å c=19.7977(19)Å
α=90.00° β=90.256(2)° γ=90.00°
2(C16H18FN3O3),2.5H2O
2(C16H18FN3O3),2.5H2O
Crystal Growth & Design (2008) 8, 12 4343
a=17.5341(11)Å b=8.9942(6)Å c=19.9186(13)Å
α=90.00° β=90.4110(10)° γ=90.00°
C16H14ClN3O4S
C16H14ClN3O4S
Crystal Growth & Design (2011) 11, 5 1930
a=7.8871(5)Å b=7.8871(5)Å c=51.100(7)Å
α=90.00° β=90.00° γ=90.00°
C22H20Br2N4O6S2
C22H20Br2N4O6S2
Crystal Growth & Design (2011) 11, 5 1930
a=8.181(3)Å b=8.421(3)Å c=10.250(4)Å
α=98.774(6)° β=95.521(6)° γ=114.520(6)°
C18H17ClN4O7S
C18H17ClN4O7S
Crystal Growth & Design (2011) 11, 5 1930
a=5.2214(4)Å b=9.5860(8)Å c=20.1540(17)Å
α=85.2220(10)° β=88.7590(10)° γ=74.8260(10)°
C24H26N4O6S2
C24H26N4O6S2
Crystal Growth & Design (2011) 11, 5 1930
a=10.3170(9)Å b=12.3913(10)Å c=20.0553(17)Å
α=90.00° β=103.7280(10)° γ=90.00°
C22H19ClN4O7.5S
C22H19ClN4O7.5S
Crystal Growth & Design (2011) 11, 5 1930
a=8.0230(6)Å b=8.3201(6)Å c=17.5479(12)Å
α=77.7340(10)° β=77.5200(10)° γ=81.2860(10)°
C27H26O9
C27H26O9
Crystal Growth & Design (2011) 11, 9 4135
a=7.3706(6)Å b=15.8001(10)Å c=19.8972(14)Å
α=90.00° β=92.933(7)° γ=90.00°
C27H26O8
C27H26O8
Crystal Growth & Design (2011) 11, 9 4135
a=7.7321(9)Å b=16.1990(19)Å c=19.558(3)Å
α=90.00° β=101.095(12)° γ=90.00°
2-(2,6-dichlorophenylamine)phenylacetoxyacetic acid
C16H13Cl2NO4
Crystal Growth & Design (2013) 13, 4 1590
a=12.284(3)Å b=8.198(2)Å c=15.484(4)Å
α=90.00° β=96.174(4)° γ=90.00°
Aceclofenac-cytosine
C20H18Cl2N4O5
Crystal Growth & Design (2013) 13, 4 1590
a=11.2960(10)Å b=8.7429(8)Å c=20.8507(19)Å
α=90.00° β=98.0120(10)° γ=90.00°
Aceclofenac-piperazine(0.5)
C18H18Cl2N2O4
Crystal Growth & Design (2013) 13, 4 1590
a=9.1898(11)Å b=5.5983(7)Å c=34.890(4)Å
α=90.00° β=94.038(2)° γ=90.00°
C42H36Cl4N4O9
C42H36Cl4N4O9
Crystal Growth & Design (2013) 13, 4 1590
a=7.5085(5)Å b=11.9908(8)Å c=22.2488(15)Å
α=90.00° β=91.5690(10)° γ=90.00°
C24H26N4O8S2
C24H26N4O8S2
Crystal Growth & Design (2011) 11, 5 1930
a=8.7426(8)Å b=5.2061(5)Å c=27.7269(19)Å
α=90.00° β=102.935(2)° γ=90.00°